BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36727810)

  • 1. Establishing a core outcomes set for massive transfusion: An Eastern Association for the Surgery of Trauma modified Delphi method consensus study.
    Gelbard RB; Nahmias J; Byerly S; Ziesmann M; Stein D; Haut ER; Smith JW; Boltz M; Zarzaur B; Callum J; Cotton BA; Cripps M; Gunter OL; Holcomb JB; Kerby J; Kornblith LZ; Moore EE; Riojas CM; Schreiber M; Sperry JL; Yeh DD
    J Trauma Acute Care Surg; 2023 Jun; 94(6):784-790. PubMed ID: 36727810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a core outcome set for blunt cerebrovascular injury: an EAST modified Delphi method consensus study.
    Ziesmann M; Byerly S; Yeh DD; Boltz M; Gelbard R; Haut ER; Smith JW; Stein DM; Zarzaur BL; Bensard DD; Biffl WL; Boyd A; Brommeland T; Cothren Burlew C; Fabian T; Lauerman M; Leichtle S; Moore EE; Timmons S; Vogt K; Nahmias J
    Trauma Surg Acute Care Open; 2023; 8(1):e001017. PubMed ID: 37342820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A core outcome set for acute necrotizing pancreatitis: An Eastern Association for the Surgery of Trauma modified Delphi method consensus study.
    Farrell MS; Alseidi A; Byerly S; Fockens P; Giberson FA; Glaser J; Horvath K; Jones D; Luckhurst C; Mowery N; Robinson BRH; Rodriguez A; Singh VK; Siriwardena AK; Vege SS; Trikudanathan G; Visser BC; Voermans RP; Yeh DD; Gelbard RB
    J Trauma Acute Care Surg; 2024 Jun; 96(6):965-970. PubMed ID: 38407209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
    Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A core outcome set for resuscitative endovascular balloon occlusion of the aorta: A consensus based approach using a modified Delphi method.
    Nahmias J; Byerly S; Stein D; Haut ER; Smith JW; Gelbard R; Ziesmann M; Boltz M; Zarzaur B; Biffl WL; Brenner M; DuBose J; Fox C; Galante J; Martin M; Moore EE; Moore L; Morrison J; Norii T; Scalea T; Yeh DD
    J Trauma Acute Care Surg; 2022 Jan; 92(1):144-151. PubMed ID: 34554137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A core outcome set for appendicitis: A consensus approach utilizing modified Delphi methodology.
    Butts CA; Byerly S; Nahmias J; Gelbard R; Ziesmann M; Bruns B; Davidson GH; Di Saverio S; Esposito TJ; Fischkoff K; Joseph B; Kaafarani H; Mentula P; Podda M; Sakran JV; Salminen P; Sammalkorpi H; Sawyer RG; Skeete D; Tesoriero R; Yeh DD
    J Trauma Acute Care Surg; 2024 Mar; 96(3):487-492. PubMed ID: 37751156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Round versus Real-Time Delphi survey approach for achieving consensus in the COHESION core outcome set: a randomised trial.
    Quirke FA; Battin MR; Bernard C; Biesty L; Bloomfield FH; Daly M; Finucane E; Haas DM; Healy P; Hurley T; Koskei S; Meher S; Molloy EJ; Niaz M; Bhraonáin EN; Okaronon CO; Tabassum F; Walker K; Webbe JRH; Parkes MJ; Kirkham JJ; Devane D
    Trials; 2023 Jul; 24(1):461. PubMed ID: 37468987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials.
    Tambor E; Robinson M; Hsu L; Chang HY; Al Naber J;
    BMC Med Res Methodol; 2021 Oct; 21(1):219. PubMed ID: 34666680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Round compared to Real-Time Delphi for consensus in core outcome set (COS) development: a randomised trial.
    Quirke FA; Healy P; Bhraonáin EN; Daly M; Biesty L; Hurley T; Walker K; Meher S; Haas DM; Bloomfield FH; Kirkham JJ; Molloy EJ; Devane D
    Trials; 2021 Feb; 22(1):142. PubMed ID: 33588938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core outcome set for studies investigating management of selective fetal growth restriction in twins.
    Townsend R; Duffy JMN; Sileo F; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ; Khalil A;
    Ultrasound Obstet Gynecol; 2020 May; 55(5):652-660. PubMed ID: 31273879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core Outcome Set for Actinic Keratosis Clinical Trials.
    Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
    JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals.
    van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO;
    Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology in core outcome set (COS) development: the impact of patient interviews and using a 5-point versus a 9-point Delphi rating scale on core outcome selection in a COS development study.
    Remus A; Smith V; Wuytack F
    BMC Med Res Methodol; 2021 Jan; 21(1):10. PubMed ID: 33413129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Core Outcome Set and Minimum Reporting Set for intervention studies in growth restriction in the NEwbOrN (COSNEON): study protocol for a Delphi study.
    Knol M; Wang H; Bloomfield F; Piet T; Damhuis S; Khalil A; Ganzevoort W; Gordijn S
    Trials; 2019 Aug; 20(1):511. PubMed ID: 31420053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study.
    Tellum T; Naftalin J; Chapron C; Dueholm M; Guo SW; Hirsch M; Larby ER; Munro MG; Saridogan E; van der Spuy ZM; Jurkovic D
    Hum Reprod; 2022 Aug; 37(9):2012-2031. PubMed ID: 35906919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international Delphi consensus process to determine a common data element and core outcome set for frailty: FOCUS (The Frailty Outcomes Consensus Project).
    Prorok JC; Williamson PR; Shea B; Rolfson D; Mañas LR; Cesari M; Kim P; Muscedere J
    BMC Geriatr; 2022 Apr; 22(1):284. PubMed ID: 35382752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a National Trauma Research Action Plan: Results from the long-term outcomes research gap Delphi survey.
    Herrera-Escobar JP; Reidy E; Phuong J; Brasel KJ; Cuschieri J; Fallat M; Potter BK; Price MA; Bulger EM; Haider AH; Bonne S; Brasel KJ; Cuschieri J; de Roon-Cassini T; Dicker RA; Fallat M; Ficke JR; Gabbe B; Gibran NS; Heinemann AW; Ho V; Kao LS; Kellam JF; Kurowski BG; Levy-Carrick NC; Livingston D; Mandell SP; Manley GT; Michetti CP; Miller AN; Newcomb A; Okonkwo D; Potter BK; Seamon M; Stein D; Wagner AK; Whyte J; Yonclas P; Zatzick D; Zielinski MD;
    J Trauma Acute Care Surg; 2022 Dec; 93(6):854-862. PubMed ID: 35972140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.